Advisory Research’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-76,153
Closed -$1.69M 291
2015
Q4
$1.69M Sell
76,153
-12,317
-14% -$256K 0.03% 160
2015
Q3
$1.5M Sell
88,470
-17,395
-16% -$271K 0.02% 186
2015
Q2
$1.46M Sell
105,865
-1,570
-1% -$20.9K 0.02% 206
2015
Q1
$1.47M Sell
107,435
-101,940
-49% -$1.18M 0.02% 210
2014
Q4
$2.21M Sell
209,375
-1,070
-0.5% -$12.7K 0.02% 197
2014
Q3
$2.63M Sell
210,445
-35,330
-14% -$493K 0.03% 186
2014
Q2
$3.36M Sell
245,775
-13,860
-5% -$181K 0.03% 178
2014
Q1
$3.13M Buy
259,635
+186,800
+256% +$2.14M 0.03% 167
2013
Q4
$895K Sell
72,835
-48,305
-40% -$567K 0.01% 249
2013
Q3
$1.23M Buy
+121,140
New +$1.13M 0.01% 230

Other funds holding OME

Advisory Research's OME Position: Q1 2016 in Review

Advisory Research sold out of Omega Protein (OME) in Q1 2016, closing a stake of 76,153 shares — an estimated $1.69M sold.

Advisory Research first reported a position in OME in Q3 2013 and held it in 10 quarters. The position peaked at $3.36M in Q2 2014. 141 funds tracked by Wall St. Rank hold OME as of Q1 2016.

  • Advisory Research reported no remaining Omega Protein position as of Q1 2016 after selling out during the quarter.
  • Advisory Research sold 76,153 Omega Protein shares in Q1 2016, an estimated $1.69M.
  • Advisory Research first reported a position in Omega Protein in Q3 2013 and held it in 10 quarters.
  • Advisory Research's Omega Protein position peaked at $3.36M in Q2 2014.
  • 141 funds tracked by Wall St. Rank held Omega Protein as of Q1 2016.

Based on Advisory Research's 13F filing for Q1 2016, filed 16 May 2016.